Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates

Détails

ID Serval
serval:BIB_AA79106E3A7E
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates
Périodique
European Journal of Biochemistry
Auteur⸱e⸱s
Cloutier  S. M., Kundig  C., Felber  L. M., Fattah  O. M., Chagas  J. R., Gygi  C. M., Jichlinski  P., Leisinger  H. J., Deperthes  D.
ISSN
0014-2956
Statut éditorial
Publié
Date de publication
02/2004
Peer-reviewed
Oui
Volume
271
Numéro
3
Pages
607-13
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Feb
Résumé
The reactive site loop of serpins undoubtedly defines in part their ability to inhibit a particular enzyme. Exchanges in the reactive loop of serpins might reassign the targets and modify the serpin-protease interaction kinetics. Based on this concept, we have developed a procedure to change the specificity of known serpins. First, reactive loops are very good substrates for the target enzymes. Therefore, we have used the phage-display technology to select from a pentapeptide phage library the best substrates for the human prostate kallikrein hK2 [Cloutier, S.M., Chagas, J.R., Mach, J.P., Gygi, C.M., Leisinger, H.J. & Deperthes, D. (2002) Eur. J. Biochem. 269, 2747-2754]. Selected substrates were then transplanted into the reactive site loop of alpha1-antichymotrypsin to generate new variants of this serpin, able to inhibit the serine protease. Thus, we have developed some highly specific alpha1-antichymotrypsin variants toward human kallikrein 2 which also show high reactivity. These inhibitors might be useful to help elucidate the importance of hK2 in prostate cancer progression.
Mots-clé
Bacteriophages/*genetics Base Sequence Blotting, Western DNA Primers Humans Hydrolysis Kinetics Mutagenesis, Site-Directed Recombinant Proteins/pharmacology Serine Proteinase Inhibitors/*pharmacology Tissue Kallikreins/*antagonists & inhibitors
Pubmed
Web of science
Open Access
Oui
Création de la notice
21/01/2008 17:10
Dernière modification de la notice
20/08/2019 16:14
Données d'usage